SG Americas Securities
IONS icon

SG Americas Securities’s Ionis Pharmaceuticals IONS Stock Holding History

SG Americas Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.75M Buy
63,295
+29,886
+89% +$2.36M 0.01% 1055
2025
Q4 		$2.64M Buy
33,409
+28,259
+549% +$2.13M ﹤0.01% 1380
2025
Q3 		$337K Buy
+5,150
New +$251K ﹤0.01% 2403
2025
Q2 		– Sell
-20,050
Closed -$605K – 3255
2025
Q1 		$605K Sell
20,050
-3,877
-16% -$127K ﹤0.01% 1614
2024
Q4 		$836K Buy
23,927
+16,508
+223% +$617K ﹤0.01% 950
2024
Q3 		$297K Buy
+7,419
New +$345K ﹤0.01% 2154
2024
Q2 		– Sell
-7,582
Closed -$329K – 3060
2024
Q1 		$329K Buy
7,582
+1,453
+24% +$69.3K ﹤0.01% 1638
2023
Q4 		$310K Sell
6,129
-35,442
-85% -$1.7M ﹤0.01% 1812
2023
Q3 		$1.89M Buy
41,571
+22,078
+113% +$911K 0.02% 776
2023
Q2 		$800K Buy
+19,493
New +$749K 0.01% 1173
2022
Q4 		– Sell
-12,698
Closed -$562K – 3208
2022
Q3 		$562K Sell
12,698
-59,859
-82% -$2.52M 0.01% 1447
2022
Q2 		$2.69M Buy
72,557
+60,966
+526% +$2.3M 0.03% 589
2022
Q1 		$429K Sell
11,591
-1,341
-10% -$43.9K ﹤0.01% 1982
2021
Q4 		$394K Sell
12,932
-6,789
-34% -$214K ﹤0.01% 2302
2021
Q3 		$661K Buy
19,721
+8,472
+75% +$319K ﹤0.01% 2268
2021
Q2 		$449K Sell
11,249
-34,559
-75% -$1.35M ﹤0.01% 1985
2021
Q1 		$2.06M Buy
45,808
+14,394
+46% +$803K 0.01% 1021
2020
Q4 		$1.78M Sell
31,414
-22,721
-42% -$1.13M 0.01% 1164
2020
Q3 		$2.57M Buy
54,135
+47,769
+750% +$2.65M 0.02% 608
2020
Q2 		$375K Sell
6,366
-6,137
-49% -$341K ﹤0.01% 2344
2020
Q1 		$591K Buy
12,503
+4,338
+53% +$242K 0.01% 1709
2019
Q4 		$493K Sell
8,165
-2,041
-20% -$122K ﹤0.01% 1796
2019
Q3 		$611K Sell
10,206
-454
-4% -$29.6K 0.01% 1746
2019
Q2 		$685K Buy
10,660
+8,028
+305% +$567K ﹤0.01% 1693
2019
Q1 		$214K Sell
2,632
-10,293
-80% -$664K ﹤0.01% 2512
2018
Q4 		$699K Buy
12,925
+9,423
+269% +$481K 0.01% 1610
2018
Q3 		$181K Sell
3,502
-75,242
-96% -$3.54M ﹤0.01% 2610
2018
Q2 		$3.28M Buy
78,744
+70,082
+809% +$3.11M 0.03% 635
2018
Q1 		$382K Buy
+8,662
New +$440K ﹤0.01% 2030
2017
Q4 		– Sell
-2,346
Closed -$119K – 3409
2017
Q3 		$119K Sell
2,346
-3,969
-63% -$208K ﹤0.01% 3059
2017
Q2 		$321K Buy
6,315
+1,489
+31% +$69.3K ﹤0.01% 2132
2017
Q1 		$194K Sell
4,826
-13,178
-73% -$592K ﹤0.01% 2461
2016
Q4 		$861K Buy
+18,004
New +$712K 0.01% 1388
2016
Q2 		– Sell
-17,214
Closed -$697K – 2799
2016
Q1 		$697K Buy
17,214
+2,789
+19% +$113K 0.01% 1551
2015
Q4 		$893K Sell
14,425
-11,929
-45% -$644K 0.01% 1219
2015
Q3 		$1.06M Buy
26,354
+12,597
+92% +$652K 0.01% 817
2015
Q2 		$792K Buy
13,757
+9,338
+211% +$594K 0.01% 1190
2015
Q1 		$281K Sell
4,419
-7,418
-63% -$503K ﹤0.01% 1716
2014
Q4 		$731K Sell
11,837
-63,965
-84% -$3.16M ﹤0.01% 1396
2014
Q3 		$2.94M Buy
+75,802
New +$2.69M 0.02% 713
2014
Q2 		– Sell
-19,077
Closed -$824K – 2607
2014
Q1 		$824K Buy
19,077
+16,292
+585% +$790K ﹤0.01% 1220
2013
Q4 		$111K Sell
2,785
-19,704
-88% -$702K ﹤0.01% 2356
2013
Q3 		$844K Buy
22,489
+1,447
+7% +$43.2K ﹤0.01% 1360
2013
Q2 		$565K Buy
+21,042
New +$447K ﹤0.01% 1202

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SG Americas Securities's IONS Position: Q1 2026 in Review

SG Americas Securities increased its Ionis Pharmaceuticals (IONS) stake by 89% in Q1 2026, buying an estimated $2.36M and bringing the position to 63,295 shares worth $4.75M. The position accounts for 0.01% of the portfolio, ranked #1055.

SG Americas Securities first reported a position in IONS in Q2 2013 and has held it in 44 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • SG Americas Securities held 63,295 shares of Ionis Pharmaceuticals worth $4.75M as of Q1 2026.
  • SG Americas Securities bought 29,886 Ionis Pharmaceuticals shares in Q1 2026, an estimated $2.36M.
  • Ionis Pharmaceuticals made up 0.01% of SG Americas Securities's portfolio in Q1 2026, its #1055 holding.
  • SG Americas Securities first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 44 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.